Sugiura I - Search Results

1

[Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].

Shimazaki C, Murakami H, Sawamura M, Matsuda M, Kinoshita T, Hata H, Sugiura I, Tsushita K, Nagura E, Kosugi H, Itoh J, Shimizu K. Shimazaki C, et al. Among authors: sugiura i. Rinsho Ketsueki. 2010 Apr;51(4):245-52. Rinsho Ketsueki. 2010. PMID: 20467220 Japanese.

2

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.

Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H. Nishiwaki S, et al. Among authors: sugiura i. EJHaem. 2023 Mar 20;4(2):358-369. doi: 10.1002/jha2.677. eCollection 2023 May. EJHaem. 2023. PMID: 37206256 Free PMC article.

3

[Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].

Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E. Shimizu K, et al. Among authors: sugiura i. Rinsho Ketsueki. 2006 Apr;47(4):303-9. Rinsho Ketsueki. 2006. PMID: 16715965 Japanese.

4

[Frequency and prognostic value of chromosome abnormalities in multiple myeloma].

Kurahashi S, Sawamoto A, Sugimoto T, Narimatsu H, Iwasaki T, Adachi T, Suzuki H, Hayakawa F, Sugiura I. Kurahashi S, et al. Among authors: sugiura i. Rinsho Ketsueki. 2007 Nov;48(11):1455-61. Rinsho Ketsueki. 2007. PMID: 18080502 Japanese.

5

Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.

Inamoto Y, Kurahashi S, Imahashi N, Fukushima N, Adachi T, Kinoshita T, Tsushita K, Miyamura K, Naoe T, Sugiura I. Inamoto Y, et al. Among authors: sugiura i. Am J Hematol. 2009 May;84(5):283-6. doi: 10.1002/ajh.21390. Am J Hematol. 2009. PMID: 19338045 Free article.

6

Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma.

Murakami H, Shimizu K, Sawamura M, Suzuki K, Sugiura I, Kosugi H, Shimazaki C, Taniwaki M, Abe M, Takagi T. Murakami H, et al. Among authors: sugiura i. Int J Hematol. 2009 Jun;89(5):636-41. doi: 10.1007/s12185-009-0314-5. Epub 2009 Apr 28. Int J Hematol. 2009. PMID: 19399582 Clinical Trial.

7

[Analysis of high-risk multiple myeloma patients treated with high-dose chemotherapy].

Kurahashi S, Suzuki K, Sawamoto A, Adachi T, Iwasaki T, Suzuki H, Sugimoto T, Narimatsu H, Hayakawa F, Sugiura I. Kurahashi S, et al. Among authors: sugiura i. Rinsho Ketsueki. 2010 Mar;51(3):174-80. Rinsho Ketsueki. 2010. PMID: 20379111 Japanese.

8

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.

Tanaka T, Shimada K, Yamamoto K, Hirooka Y, Niwa Y, Sugiura I, Kitamura K, Kosugi H, Kinoshita T, Goto H, Nakamura S. Tanaka T, et al. Among authors: sugiura i. Ann Hematol. 2012 Mar;91(3):383-90. doi: 10.1007/s00277-011-1306-0. Epub 2011 Aug 6. Ann Hematol. 2012. PMID: 21822617

9

Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma.

Sugiura I, Terabe S, Kinoshita T, Yamamoto K, Sawa M, Ozawa Y, Atsuta Y, Suzuki R, Shimizu K. Sugiura I, et al. Int J Hematol. 2015 Oct;102(4):434-40. doi: 10.1007/s12185-015-1846-5. Epub 2015 Aug 23. Int J Hematol. 2015. PMID: 26298823 Clinical Trial.

10

[Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102)].

Ogiya D, Shibayama H, Nakatani E, Ando K, Suzuki K, Kuroda Y, Uchida T, Maruyama D, Matsumoto M, Matsue K, Iida S, Terui Y, Ri M, Chou T, Aotsuka N, Tabata S, Konishi J, Ohashi K, Shinagawa A, Sugiura I, Kuroda J, Miyamoto T, Ogura M, Tobinai K, Kanakura Y, Hotta T. Ogiya D, et al. Among authors: sugiura i. Rinsho Ketsueki. 2016;57(11):2311-2318. doi: 10.11406/rinketsu.57.2311. Rinsho Ketsueki. 2016. PMID: 27941278 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters